A standard operating procedure for assessing liquid handler performance in high-throughput screening

被引:34
作者
Taylor, PB
Ashman, S
Baddeley, SM
Bartram, SL
Battle, CD
Bond, BC
Clements, YM
Gaul, NJ
McAllister, WE
Mostacero, JA
Ramon, F
Wilson, JM
Hertzberg, RP
Pope, AJ
Macarron, R
机构
[1] GlaxoSmithKline, Dept Mol Screening, King Of Prussia, PA USA
[2] Dept Assay Methodol Dev, Harlow, Essex, England
[3] Dept Stat Sci, Harlow, Essex, England
[4] Cheminformat, King Of Prussia, PA USA
[5] Cheminformat, Stevenage, Herts, England
[6] Syst Res, King Of Prussia, PA USA
关键词
D O I
10.1177/1087057102238630
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The thrust of early drug discovery in recent years has been toward the configuration of homogeneous miniaturized assays. This has allowed organizations to contain costs in the face of exponential increases in the number of screening assays that need to be run to remain competitive. Miniaturization brings with it an increasing dependence on instrumentation, which over the past several years has seen the development of nanodispensing capability and sophisticated detection strategies. To maintain confidence in the data generated from miniaturized assays, it is critical to ensure that both compounds and reagents have been delivered as expected to the target wells. The authors have developed a standard operating procedure for liquid-handling quality control that has enabled them to evaluate performance on 2 levels. The first level provides for routine daily testing on existing instrumentation, and the second allows for more rigorous testing of new dispensing technologies. The procedure has shown itself to be useful in identifying both method programming and instrumentation performance shortcomings and has provided a means to harmonizing instrumentation usage by assay development and screening groups. The goal is that this type of procedure be used for facilitating the exchange of liquid handler performance data across the industry.
引用
收藏
页码:554 / 569
页数:16
相关论文
共 41 条
[1]  
ARNOLD BA, 1997, BIOTECHNIQUES, V25, P106
[2]  
Astle T. W., 1996, J BIOMOL SCREEN, V1, P211
[3]  
BADDELEY S, 2000, 6 ANN SBS C VANC BC
[4]  
Bateman TA, 1999, LAB ROBOTICS AUTOMAT, V11, P250, DOI 10.1002/(SICI)1098-2728(1999)11:5<250::AID-LRA2>3.0.CO
[5]  
2-1
[6]   Miniaturization of a functional transcription assay in yeast (human progesterone receptor) in the 384-and 1536-well plate format [J].
Berg, M ;
Undisz, K ;
Thiericke, R ;
Moore, T ;
Posten, C .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (02) :71-76
[7]   Evaluation of liquid handling conditions in microplates [J].
Berg, M ;
Undisz, K ;
Thiericke, R ;
Zimmermann, P ;
Moore, T ;
Posten, C .
JOURNAL OF BIOMOLECULAR SCREENING, 2001, 6 (01) :47-56
[8]  
Box GEP., 1978, Statistics for experimenters
[9]   Miniaturization technologies in HTS: how fast, how small, how soon? [J].
Burbaum, JJ .
DRUG DISCOVERY TODAY, 1998, 3 (07) :313-322
[10]   The evolution of miniaturized well plates [J].
Burbaum, JJ .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (01) :5-8